 Bryan Bergman
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 52 | 2025 | 1226 | 8.530 |
Why?
| | Muscle, Skeletal | 40 | 2025 | 1712 | 5.620 |
Why?
| | Adipose Tissue | 18 | 2025 | 642 | 3.530 |
Why?
| | Triglycerides | 17 | 2024 | 525 | 3.080 |
Why?
| | Sphingolipids | 8 | 2024 | 77 | 2.780 |
Why?
| | Diabetes Mellitus, Type 2 | 23 | 2024 | 2553 | 2.760 |
Why?
| | Obesity | 35 | 2025 | 3023 | 2.540 |
Why?
| | Exercise | 15 | 2025 | 2064 | 2.480 |
Why?
| | Diglycerides | 8 | 2024 | 61 | 2.310 |
Why?
| | Insulin | 27 | 2025 | 2394 | 2.200 |
Why?
| | Blood Glucose | 29 | 2025 | 2184 | 1.670 |
Why?
| | Fasting | 7 | 2025 | 282 | 1.630 |
Why?
| | Lipid Metabolism | 13 | 2025 | 522 | 1.570 |
Why?
| | Weight Loss | 5 | 2025 | 783 | 1.530 |
Why?
| | Lipids | 5 | 2024 | 678 | 1.490 |
Why?
| | Physical Endurance | 12 | 2020 | 269 | 1.450 |
Why?
| | Glucose Clamp Technique | 22 | 2025 | 195 | 1.450 |
Why?
| | Ceramides | 7 | 2024 | 117 | 1.390 |
Why?
| | Phosphatidylcholines | 2 | 2024 | 135 | 1.300 |
Why?
| | Sarcolemma | 3 | 2024 | 42 | 1.190 |
Why?
| | Rest | 6 | 2017 | 121 | 1.160 |
Why?
| | Paracrine Communication | 2 | 2025 | 66 | 1.090 |
Why?
| | Liver | 12 | 2019 | 1867 | 1.080 |
Why?
| | Muscle Fibers, Skeletal | 5 | 2024 | 216 | 1.070 |
Why?
| | Lipogenesis | 4 | 2017 | 61 | 1.070 |
Why?
| | Fatty Acids, Nonesterified | 10 | 2022 | 158 | 1.000 |
Why?
| | Intra-Abdominal Fat | 4 | 2022 | 91 | 0.940 |
Why?
| | Prediabetic State | 5 | 2016 | 249 | 0.920 |
Why?
| | Glucose | 9 | 2023 | 1029 | 0.870 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2023 | 7 | 0.840 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2023 | 134 | 0.830 |
Why?
| | Glucose Tolerance Test | 11 | 2021 | 367 | 0.830 |
Why?
| | Pancreas | 1 | 2025 | 320 | 0.780 |
Why?
| | Dietary Fats | 6 | 2020 | 305 | 0.770 |
Why?
| | Subcutaneous Fat | 4 | 2025 | 81 | 0.760 |
Why?
| | Tandem Mass Spectrometry | 4 | 2024 | 538 | 0.760 |
Why?
| | Carnitine | 3 | 2024 | 83 | 0.760 |
Why?
| | Adult | 46 | 2025 | 37715 | 0.730 |
Why?
| | Diabetes Mellitus, Type 1 | 18 | 2019 | 3661 | 0.710 |
Why?
| | Humans | 90 | 2025 | 136965 | 0.690 |
Why?
| | Male | 67 | 2025 | 67386 | 0.690 |
Why?
| | Athletes | 7 | 2024 | 425 | 0.660 |
Why?
| | Female | 65 | 2025 | 73002 | 0.640 |
Why?
| | Energy Metabolism | 5 | 2025 | 919 | 0.600 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1452 | 0.590 |
Why?
| | Middle Aged | 31 | 2025 | 33226 | 0.540 |
Why?
| | Glucose Intolerance | 4 | 2014 | 146 | 0.540 |
Why?
| | Lactic Acid | 7 | 2009 | 306 | 0.530 |
Why?
| | Oxidation-Reduction | 8 | 2024 | 1073 | 0.530 |
Why?
| | Adipocytes | 2 | 2023 | 226 | 0.520 |
Why?
| | Hypoglycemic Agents | 2 | 2023 | 1298 | 0.520 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 76 | 0.520 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 577 | 0.510 |
Why?
| | Choristoma | 1 | 2015 | 21 | 0.480 |
Why?
| | Body Composition | 10 | 2025 | 690 | 0.470 |
Why?
| | Mitochondria, Muscle | 5 | 2021 | 116 | 0.450 |
Why?
| | Myocardium | 2 | 2009 | 895 | 0.420 |
Why?
| | Hyperglycemia | 3 | 2014 | 348 | 0.410 |
Why?
| | Smoking | 2 | 2012 | 1609 | 0.400 |
Why?
| | Benzhydryl Compounds | 1 | 2013 | 74 | 0.390 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2012 | 55 | 0.390 |
Why?
| | Atrial Function | 2 | 2009 | 10 | 0.380 |
Why?
| | Phenols | 1 | 2013 | 104 | 0.380 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5530 | 0.380 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 112 | 0.380 |
Why?
| | Islets of Langerhans | 6 | 2025 | 793 | 0.380 |
Why?
| | Body Mass Index | 7 | 2025 | 2416 | 0.380 |
Why?
| | Adiposity | 5 | 2024 | 527 | 0.370 |
Why?
| | Homeostasis | 1 | 2016 | 616 | 0.370 |
Why?
| | Fatty Acids | 5 | 2024 | 446 | 0.370 |
Why?
| | Lipoprotein Lipase | 2 | 2015 | 59 | 0.370 |
Why?
| | Hyperinsulinism | 3 | 2024 | 123 | 0.360 |
Why?
| | Physical Fitness | 4 | 2004 | 208 | 0.360 |
Why?
| | Glycerol | 5 | 2015 | 91 | 0.340 |
Why?
| | Animals | 29 | 2024 | 36882 | 0.340 |
Why?
| | Sex Characteristics | 5 | 2024 | 766 | 0.330 |
Why?
| | Incretins | 1 | 2010 | 22 | 0.330 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 46 | 0.320 |
Why?
| | Sleep Deprivation | 3 | 2021 | 180 | 0.320 |
Why?
| | Sleep | 3 | 2021 | 788 | 0.320 |
Why?
| | Pyrazines | 1 | 2010 | 85 | 0.310 |
Why?
| | Triazoles | 1 | 2010 | 150 | 0.300 |
Why?
| | Physical Education and Training | 2 | 1999 | 76 | 0.300 |
Why?
| | Rats | 6 | 2024 | 5544 | 0.290 |
Why?
| | Cytosol | 2 | 2020 | 229 | 0.290 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2009 | 75 | 0.290 |
Why?
| | Insulin-Secreting Cells | 2 | 2010 | 377 | 0.290 |
Why?
| | Thinness | 2 | 2007 | 94 | 0.280 |
Why?
| | Energy Intake | 4 | 2025 | 501 | 0.270 |
Why?
| | Endoplasmic Reticulum | 2 | 2020 | 269 | 0.260 |
Why?
| | Pulmonary Gas Exchange | 3 | 2007 | 122 | 0.250 |
Why?
| | T-Lymphocytes | 5 | 2000 | 1975 | 0.240 |
Why?
| | Young Adult | 13 | 2024 | 13218 | 0.240 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 176 | 0.240 |
Why?
| | Palmitates | 2 | 2018 | 18 | 0.230 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2019 | 178 | 0.230 |
Why?
| | Heart Rate | 1 | 2008 | 794 | 0.220 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 42 | 0.210 |
Why?
| | Body Weight | 2 | 2025 | 985 | 0.210 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 59 | 0.210 |
Why?
| | Prostatic Neoplasms | 3 | 2020 | 1041 | 0.210 |
Why?
| | Caloric Restriction | 1 | 2025 | 124 | 0.210 |
Why?
| | Mice, Inbred NOD | 5 | 2015 | 596 | 0.200 |
Why?
| | Catecholamines | 1 | 2023 | 87 | 0.200 |
Why?
| | Circadian Clocks | 1 | 2023 | 51 | 0.200 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 91 | 0.200 |
Why?
| | Adiponectin | 3 | 2015 | 243 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2017 | 458 | 0.200 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.200 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 21 | 0.200 |
Why?
| | Fatty Liver | 2 | 2016 | 242 | 0.200 |
Why?
| | Ribonucleoside Diphosphate Reductase | 1 | 2022 | 6 | 0.190 |
Why?
| | Gluconeogenesis | 2 | 2018 | 79 | 0.190 |
Why?
| | Adipokines | 1 | 2022 | 47 | 0.190 |
Why?
| | Oxygen Consumption | 4 | 2016 | 702 | 0.190 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 85 | 0.190 |
Why?
| | Blotting, Western | 3 | 2016 | 1216 | 0.190 |
Why?
| | Biopsy | 3 | 2018 | 1083 | 0.190 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.180 |
Why?
| | Subcellular Fractions | 2 | 2021 | 79 | 0.180 |
Why?
| | Histone Deacetylases | 1 | 2023 | 211 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 208 | 0.180 |
Why?
| | Vasodilation | 1 | 2025 | 497 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2019 | 3556 | 0.180 |
Why?
| | Interleukin-13 | 1 | 2022 | 147 | 0.180 |
Why?
| | Physical Conditioning, Animal | 1 | 2024 | 253 | 0.180 |
Why?
| | Stearoyl-CoA Desaturase | 3 | 2012 | 65 | 0.180 |
Why?
| | Bone Marrow | 1 | 2023 | 298 | 0.180 |
Why?
| | Interleukin-8 | 1 | 2022 | 270 | 0.180 |
Why?
| | Exercise Test | 5 | 2015 | 617 | 0.180 |
Why?
| | Resistance Training | 1 | 2024 | 169 | 0.180 |
Why?
| | Lipolysis | 2 | 2018 | 46 | 0.170 |
Why?
| | Bone Remodeling | 1 | 2021 | 76 | 0.170 |
Why?
| | Diabetic Angiopathies | 3 | 2011 | 260 | 0.170 |
Why?
| | Knee | 1 | 2001 | 68 | 0.170 |
Why?
| | Electric Stimulation | 1 | 2001 | 272 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 139 | 0.160 |
Why?
| | Antigens, Surface | 1 | 2000 | 152 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 94 | 0.160 |
Why?
| | Autophagy-Related Proteins | 2 | 2017 | 46 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 407 | 0.160 |
Why?
| | Palmitic Acid | 2 | 2010 | 41 | 0.160 |
Why?
| | Autoantigens | 2 | 2000 | 421 | 0.150 |
Why?
| | Calorimetry, Indirect | 3 | 2019 | 84 | 0.150 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2018 | 34 | 0.150 |
Why?
| | Guanosine Triphosphate | 1 | 2018 | 90 | 0.150 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2018 | 58 | 0.150 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 48 | 0.150 |
Why?
| | Kinetics | 6 | 2006 | 1635 | 0.140 |
Why?
| | Primary Cell Culture | 1 | 2019 | 171 | 0.140 |
Why?
| | Interleukin-6 | 1 | 2022 | 781 | 0.140 |
Why?
| | Absorptiometry, Photon | 4 | 2025 | 264 | 0.140 |
Why?
| | Basal Metabolism | 2 | 2008 | 61 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2001 | 429 | 0.140 |
Why?
| | Mice | 14 | 2024 | 17705 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2018 | 278 | 0.140 |
Why?
| | Metabolic Syndrome | 2 | 2013 | 354 | 0.140 |
Why?
| | Cohort Studies | 5 | 2021 | 5688 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1229 | 0.130 |
Why?
| | Diet | 4 | 2013 | 1279 | 0.130 |
Why?
| | Cell Nucleus | 1 | 2020 | 607 | 0.130 |
Why?
| | Diet, Western | 3 | 2023 | 81 | 0.130 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2017 | 7 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2552 | 0.130 |
Why?
| | Extracellular Vesicles | 2 | 2018 | 147 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2024 | 612 | 0.130 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2018 | 113 | 0.130 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2017 | 45 | 0.130 |
Why?
| | Metabolomics | 3 | 2019 | 681 | 0.130 |
Why?
| | Phospholipids | 3 | 2018 | 219 | 0.130 |
Why?
| | Biological Transport | 1 | 2017 | 401 | 0.130 |
Why?
| | Pregnancy | 7 | 2024 | 6736 | 0.120 |
Why?
| | Phosphorylation | 4 | 2015 | 1746 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 451 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2023 | 1747 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3148 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 100 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 194 | 0.120 |
Why?
| | Metformin | 1 | 2019 | 336 | 0.120 |
Why?
| | Pain | 1 | 2001 | 750 | 0.120 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1229 | 0.120 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2012 | 59 | 0.120 |
Why?
| | Insulinoma | 2 | 1999 | 27 | 0.120 |
Why?
| | Amino Acids | 1 | 2019 | 493 | 0.120 |
Why?
| | Weight Gain | 1 | 2019 | 535 | 0.120 |
Why?
| | Biomarkers | 4 | 2023 | 4095 | 0.110 |
Why?
| | Adolescent | 12 | 2024 | 21471 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2014 | 2788 | 0.110 |
Why?
| | Circadian Rhythm | 1 | 2019 | 474 | 0.110 |
Why?
| | Algorithms | 3 | 2015 | 1700 | 0.110 |
Why?
| | Cell Hypoxia | 1 | 2015 | 226 | 0.110 |
Why?
| | Venous Thromboembolism | 1 | 2018 | 314 | 0.110 |
Why?
| | Coronary Artery Disease | 2 | 2011 | 698 | 0.110 |
Why?
| | Oxygen | 2 | 2015 | 946 | 0.110 |
Why?
| | Mitochondria | 2 | 2018 | 949 | 0.110 |
Why?
| | Receptors, AMPA | 1 | 2015 | 140 | 0.110 |
Why?
| | Somatostatin | 1 | 2014 | 58 | 0.110 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 625 | 0.100 |
Why?
| | Fructose | 1 | 2014 | 112 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1100 | 0.100 |
Why?
| | Regression Analysis | 1 | 2016 | 1007 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 292 | 0.100 |
Why?
| | Neurodegenerative Diseases | 1 | 2015 | 138 | 0.100 |
Why?
| | Clone Cells | 4 | 2000 | 263 | 0.100 |
Why?
| | Cytoplasmic Granules | 1 | 1994 | 95 | 0.100 |
Why?
| | Leg | 3 | 1999 | 233 | 0.100 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2012 | 36 | 0.100 |
Why?
| | Macaca | 3 | 2018 | 63 | 0.100 |
Why?
| | Taxoids | 1 | 2012 | 101 | 0.090 |
Why?
| | Antigens, Neoplasm | 2 | 1994 | 316 | 0.090 |
Why?
| | Progestins | 1 | 2012 | 79 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 604 | 0.090 |
Why?
| | Coronary Vessels | 2 | 2010 | 243 | 0.090 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2013 | 135 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2574 | 0.090 |
Why?
| | Cholesterol | 2 | 2013 | 411 | 0.090 |
Why?
| | Hemodynamics | 3 | 2008 | 1062 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2013 | 302 | 0.090 |
Why?
| | Hypoxia | 1 | 2018 | 1108 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 648 | 0.090 |
Why?
| | Reference Values | 2 | 2010 | 797 | 0.090 |
Why?
| | Fenofibrate | 1 | 2011 | 27 | 0.090 |
Why?
| | Child | 9 | 2024 | 21760 | 0.080 |
Why?
| | Sitagliptin Phosphate | 1 | 2010 | 32 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 971 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 1999 | 0.080 |
Why?
| | Estradiol | 2 | 2019 | 519 | 0.080 |
Why?
| | Hypolipidemic Agents | 1 | 2011 | 91 | 0.080 |
Why?
| | Cell Line | 5 | 2022 | 2855 | 0.080 |
Why?
| | Nicotine | 1 | 2012 | 342 | 0.080 |
Why?
| | Retinoid X Receptor gamma | 1 | 2009 | 4 | 0.080 |
Why?
| | C-Peptide | 1 | 2010 | 162 | 0.080 |
Why?
| | Metabolic Clearance Rate | 2 | 2006 | 107 | 0.080 |
Why?
| | PPAR alpha | 1 | 2009 | 57 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 406 | 0.080 |
Why?
| | Expiratory Reserve Volume | 1 | 2008 | 1 | 0.080 |
Why?
| | Bicycling | 1 | 2010 | 111 | 0.080 |
Why?
| | Lipoproteins | 1 | 2010 | 166 | 0.080 |
Why?
| | Calcinosis | 1 | 2011 | 234 | 0.070 |
Why?
| | Gene Expression | 3 | 2023 | 1480 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2023 | 5733 | 0.070 |
Why?
| | Proteins | 3 | 2015 | 1003 | 0.070 |
Why?
| | Coronary Circulation | 1 | 2008 | 135 | 0.070 |
Why?
| | Ethinyl Estradiol | 1 | 1988 | 15 | 0.070 |
Why?
| | Signal Transduction | 4 | 2018 | 5047 | 0.070 |
Why?
| | Calcium | 2 | 2010 | 1180 | 0.070 |
Why?
| | Arteries | 2 | 2000 | 262 | 0.070 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 791 | 0.070 |
Why?
| | Receptor, Insulin | 1 | 2007 | 101 | 0.070 |
Why?
| | Pancreatic Neoplasms | 2 | 1999 | 832 | 0.070 |
Why?
| | Regional Blood Flow | 2 | 1999 | 476 | 0.070 |
Why?
| | Hyperphagia | 1 | 2006 | 40 | 0.060 |
Why?
| | Cardiovascular Diseases | 3 | 2018 | 2115 | 0.060 |
Why?
| | Overweight | 1 | 2011 | 576 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 549 | 0.060 |
Why?
| | Heart | 1 | 2009 | 609 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 1 | 1988 | 177 | 0.060 |
Why?
| | Infant | 3 | 2024 | 9392 | 0.060 |
Why?
| | Sex Factors | 4 | 2018 | 2060 | 0.060 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2019 | 54 | 0.050 |
Why?
| | Glucose-6-Phosphatase | 2 | 2001 | 34 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 31 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 16 | 0.050 |
Why?
| | Metabolome | 2 | 2019 | 350 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2004 | 54 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 56 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 116 | 0.050 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 57 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 44 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 53 | 0.050 |
Why?
| | Carbohydrate Metabolism | 2 | 2004 | 60 | 0.050 |
Why?
| | Aged | 6 | 2018 | 23803 | 0.050 |
Why?
| | Physical Exertion | 1 | 2004 | 209 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2024 | 197 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 43 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2809 | 0.050 |
Why?
| | Prognosis | 2 | 2023 | 3931 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2023 | 248 | 0.050 |
Why?
| | Primates | 1 | 2023 | 139 | 0.050 |
Why?
| | Time Factors | 2 | 2010 | 6786 | 0.050 |
Why?
| | Neoplasms | 1 | 2017 | 2698 | 0.040 |
Why?
| | Osteocalcin | 1 | 2021 | 36 | 0.040 |
Why?
| | Protein Binding | 2 | 2018 | 2223 | 0.040 |
Why?
| | Acute Disease | 1 | 2024 | 993 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2156 | 0.040 |
Why?
| | Swine, Miniature | 2 | 2013 | 88 | 0.040 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2015 | 193 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 320 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2111 | 0.040 |
Why?
| | Ranolazine | 1 | 2020 | 25 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 1988 | 869 | 0.040 |
Why?
| | Oxidative Stress | 2 | 2018 | 1318 | 0.040 |
Why?
| | Torque | 1 | 2001 | 84 | 0.040 |
Why?
| | Collagen Type I | 1 | 2021 | 137 | 0.040 |
Why?
| | Testosterone | 2 | 2019 | 403 | 0.040 |
Why?
| | Electrodes | 1 | 2001 | 115 | 0.040 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2022 | 205 | 0.040 |
Why?
| | Chromatography, Ion Exchange | 1 | 2000 | 54 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 45 | 0.040 |
Why?
| | Chromatography, Gel | 1 | 2000 | 129 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 222 | 0.040 |
Why?
| | Serine | 1 | 2021 | 141 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2000 | 122 | 0.040 |
Why?
| | Solubility | 1 | 2000 | 241 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 338 | 0.040 |
Why?
| | Cell Membrane | 2 | 2000 | 710 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 305 | 0.040 |
Why?
| | Glycogen | 1 | 1999 | 54 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 368 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2000 | 182 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 436 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2001 | 188 | 0.040 |
Why?
| | Eating | 1 | 2021 | 392 | 0.040 |
Why?
| | Swine | 2 | 2013 | 778 | 0.040 |
Why?
| | Glucose Transporter Type 4 | 1 | 2018 | 40 | 0.040 |
Why?
| | Glucagon | 1 | 1999 | 105 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 1999 | 165 | 0.040 |
Why?
| | Thromboplastin | 1 | 2018 | 73 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 2463 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2000 | 229 | 0.040 |
Why?
| | Postprandial Period | 1 | 1999 | 107 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1730 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 2015 | 4276 | 0.040 |
Why?
| | Perception | 1 | 2001 | 365 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 402 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1114 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2020 | 483 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2023 | 819 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 352 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2018 | 662 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 1999 | 266 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2015 | 2456 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 901 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3393 | 0.030 |
Why?
| | Nutritional Status | 1 | 1999 | 348 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 117 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 734 | 0.030 |
Why?
| | Waist Circumference | 1 | 2015 | 141 | 0.030 |
Why?
| | Deuterium | 1 | 2015 | 99 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 632 | 0.030 |
Why?
| | Androgens | 1 | 2016 | 184 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 7512 | 0.030 |
Why?
| | Lymphocyte Activation | 3 | 1994 | 1134 | 0.030 |
Why?
| | Epitopes | 1 | 1997 | 476 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1904 | 0.030 |
Why?
| | Protein Subunits | 1 | 2015 | 241 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 907 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1994 | 40 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 286 | 0.030 |
Why?
| | Culture Techniques | 1 | 1994 | 73 | 0.030 |
Why?
| | Cell Fractionation | 1 | 1994 | 55 | 0.030 |
Why?
| | Animal Feed | 1 | 2014 | 53 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1882 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 1997 | 384 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 495 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2000 | 1151 | 0.030 |
Why?
| | Memory | 1 | 2015 | 252 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 1994 | 409 | 0.030 |
Why?
| | Acyl Coenzyme A | 1 | 2013 | 31 | 0.020 |
Why?
| | Amyloid beta-Peptides | 1 | 2015 | 219 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2013 | 55 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6051 | 0.020 |
Why?
| | Risk Factors | 3 | 2012 | 10363 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2014 | 199 | 0.020 |
Why?
| | Gonanes | 1 | 2012 | 27 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2732 | 0.020 |
Why?
| | Cardiolipins | 1 | 2013 | 83 | 0.020 |
Why?
| | Anaerobic Threshold | 2 | 2004 | 28 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2015 | 581 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1994 | 942 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2015 | 433 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2015 | 503 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 1992 | 157 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 797 | 0.020 |
Why?
| | Amino Acid Sequence | 3 | 2001 | 2139 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2793 | 0.020 |
Why?
| | Abdominal Fat | 1 | 2012 | 41 | 0.020 |
Why?
| | Molecular Weight | 1 | 2012 | 330 | 0.020 |
Why?
| | Models, Statistical | 1 | 2015 | 662 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2015 | 502 | 0.020 |
Why?
| | Learning | 1 | 2015 | 412 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 2001 | 2900 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 321 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2010 | 2654 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 349 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1872 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2011 | 203 | 0.020 |
Why?
| | Hippocampus | 1 | 2015 | 897 | 0.020 |
Why?
| | Abdomen | 1 | 2010 | 126 | 0.020 |
Why?
| | Sex Distribution | 1 | 2010 | 373 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 10952 | 0.020 |
Why?
| | Conserved Sequence | 2 | 2001 | 235 | 0.020 |
Why?
| | Sequence Alignment | 2 | 2001 | 354 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5048 | 0.020 |
Why?
| | Cloning, Molecular | 2 | 2001 | 534 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 521 | 0.020 |
Why?
| | Spleen | 1 | 2010 | 514 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 2999 | 0.020 |
Why?
| | Leydig Cells | 1 | 1988 | 15 | 0.020 |
Why?
| | Gonadotropins, Pituitary | 1 | 1988 | 22 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 437 | 0.020 |
Why?
| | Environmental Monitoring | 1 | 2010 | 371 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2542 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2009 | 366 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 1992 | 845 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3574 | 0.020 |
Why?
| | Base Sequence | 2 | 2001 | 2168 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1540 | 0.020 |
Why?
| | Patient Selection | 1 | 2010 | 685 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2070 | 0.020 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 451 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3258 | 0.010 |
Why?
| | Femoral Vein | 1 | 2004 | 34 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2004 | 134 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 143 | 0.010 |
Why?
| | Alanine | 1 | 2004 | 151 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2831 | 0.010 |
Why?
| | Femoral Artery | 1 | 2004 | 182 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1786 | 0.010 |
Why?
| | Glycolysis | 1 | 2004 | 319 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2010 | 1056 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2001 | 206 | 0.010 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2000 | 22 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2001 | 227 | 0.010 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 78 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2266 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 303 | 0.010 |
Why?
| | Mice, Obese | 1 | 1999 | 66 | 0.010 |
Why?
| | Myosin Heavy Chains | 1 | 2000 | 179 | 0.010 |
Why?
| | Fishes | 1 | 1999 | 110 | 0.010 |
Why?
| | Open Reading Frames | 1 | 1999 | 131 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 392 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 372 | 0.010 |
Why?
| | Exons | 1 | 1999 | 350 | 0.010 |
Why?
| | Dogs | 1 | 1999 | 399 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1999 | 226 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1235 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1999 | 1256 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 1000 | 0.010 |
Why?
| | Models, Molecular | 1 | 1999 | 1591 | 0.010 |
Why?
| | Trinitrobenzenes | 1 | 1992 | 14 | 0.010 |
Why?
| | Adenoma, Islet Cell | 1 | 1992 | 6 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1992 | 47 | 0.010 |
Why?
| | Haptens | 1 | 1992 | 22 | 0.010 |
Why?
| | Ovalbumin | 1 | 1992 | 186 | 0.010 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1992 | 131 | 0.010 |
Why?
| | Interleukin-2 | 1 | 1992 | 449 | 0.010 |
Why?
| | Islets of Langerhans Transplantation | 1 | 1989 | 64 | 0.000 |
Why?
| | Mice, Mutant Strains | 1 | 1989 | 303 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1989 | 148 | 0.000 |
Why?
|
|
Bergman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|